Advanced Accelerator ApplicationsAdvanced Accelerator Applications
AA

Advanced Accelerator Applications

Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.

Website
2002Active628
Advertise here

About

Advanced Accelerator Applications (AAA) is a pharmaceutical company specializing in nuclear medicine, focusing on the development, manufacturing, and commercialization of radiopharmaceuticals for diagnostic and therapeutic purposes. Their products are used in oncology, neurology, cardiology, and infectious diseases.

Technology stack

detected 2026-06-16
Est. monthly stack spend~$1,440/mo
CDN
Cloudflare
EmailProofpoint
gateway-fronted
Stack
Bootstrap
Cookie consent
OneTrust
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Advanced Accelerator Applications do?

Advanced Accelerator Applications (AAA) is a pharmaceutical company specializing in nuclear medicine, focusing on the development, manufacturing, and commercialization of radiopharmaceuticals for diagnostic and therapeutic purposes. Their products are used in oncology, neurology, cardiology, and infectious diseases.

How much funding has Advanced Accelerator Applications raised?

Advanced Accelerator Applications has raised a total of $56M in funding. The most recent round on record is Grant (prize money).

Where is Advanced Accelerator Applications headquartered?

Advanced Accelerator Applications is headquartered in Saint-Genis-Pouilly, France.

When was Advanced Accelerator Applications founded?

Advanced Accelerator Applications was founded in 2002.

What industry does Advanced Accelerator Applications operate in?

Advanced Accelerator Applications operates in Pharmaceuticals, Biotechnology, Medical Devices, Oncology, Nuclear Medicine.

How many employees does Advanced Accelerator Applications have?

Advanced Accelerator Applications has approximately 628 people on record.